TrialCardiology journal2022

Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.

Eliano P Navarese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.